EirGenix' s Breast Cancer Biosimilar Receives Marketing Authorization by EC

TAIPEI, Nov. 23, 2023 /PRNewswire/ -- EirGenix Inc. (6589. TT) announced today that its trastuzumab Biosimilar medicine (EG12014) which their commercial ...

Related Keywords

,Eirgenix ,Breast ,Dancer ,Biosimilar ,Eceives ,Marketing ,Authorization ,